Rockwell Medical (RMTI) Change in Accured Expenses (2010 - 2026)

Rockwell Medical (RMTI) has reported Change in Accured Expenses for 17 consecutive years, with $1.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Accured Expenses rose 318.49% year-over-year to $1.1 million; the trailing twelve-month figure through Jun 2026 stood at $122000.0 (up 105.81% YoY), and the FY2025 full-year result was -$1.7 million, down 62.38% from the prior year.
• Change in Accured Expenses rose to $1.1 million in Q2 2026 per RMTI's latest filing, from -$1.5 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $2.9 million in Q3 2023 and bottomed at -$3.3 million in Q1 2023.
• Historically, Change in Accured Expenses has averaged -$51055.6 across 5 years, with a median of $58000.0 in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 414.84% in 2023, then jumped 320.85% in 2025.
• Over 5 years, Change in Accured Expenses stood at $1.8 million in 2022, then slumped by 63.05% to $657000.0 in 2023, then slumped by 143.07% to -$283000.0 in 2024, then surged by 320.85% to $625000.0 in 2025, then jumped by 75.84% to $1.1 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $1.1 million, -$1.5 million, and $625000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.